Purdue Pharma tentatively settles opioid lawsuits, others still pending

Oxycontin manufacturer Purdue Pharma recently reached a tentative agreement with many of the thousands of plaintiffs involved in a multidistrict lawsuit that alleges the company and some other opioid makers and distributors played a role in creating in the opioid crisis, Reuters reported.
More than a dozen other states and entities have not agreed to the deal, setting the stage for a fight with Purdue Pharma through bankruptcy proceedings, the news agency reported. North Carolina and Pennsylvania also intend to sue the Sacklers directly, according to tweets from those states’ respective

Source link

Related posts

Dietary lipids fuel GPX4-restricted enteritis resembling Crohn’s disease


AGA issues new guidance for IBD management during COVID-19 pandemic


Thiopurines offer no clear benefit over Humira monotherapy in Crohn’s maintenance


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy